Beyond ordinary. We craft stories that engage
Benign Prostatic Hyperplasia (BPH) affects many men with symptoms like weakened urinary flow and frequent urination. Current treatments typically focus on either symptom relief or slowing disease progression, but not both. Dutas T combines Dutasteride 0.5 mg and Tamsulosin 0.4 mg to address this gap and effectively enter a competitive market. This dual-action treatment both reduces prostate size and alleviates urinary symptoms, targeting comprehensive care needs. The client approached us to build a strong brand identity that clearly communicates the product's benefits and dual-action efficacy to healthcare professionals and pharmacists.
Copyright © 2025 | All Rights Reserved.
